Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · IEX Real-Time Price · USD
3.110
-0.100 (-3.12%)
At close: Jul 19, 2024, 4:00 PM
3.040
-0.070 (-2.25%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $119.20 million as of July 22, 2024. Its market cap has increased by 13.85% in one year.
Market Cap
119.20M
Enterprise Value
-2.02M
1-Year Change
13.85%
Ranking
Category
Stock Price
$3.11
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $119.20M, a decrease of -75.67%. That is a compound annual growth rate of -30.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 119.20M | 28.86% |
| Dec 29, 2023 | 92.50M | -22.85% |
| Dec 30, 2022 | 119.90M | -75.36% |
| Dec 31, 2021 | 486.70M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.13% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunic | 127.01M |
| Annovis Bio | 126.57M |
| Agenus | 125.79M |
| Relmada Therapeutics | 125.52M |
| Nuvectis Pharma | 123.35M |
| Werewolf Therapeutics | 118.20M |
| Seer, Inc. | 116.89M |
| Akoya Biosciences | 116.55M |